ResearcherNational Health Research InstitutesNo recent work listed
Kelvin K. Tsai
Matched on ORCID iD 0000-0002-1612-2868; OpenAlex author ID A5089538326. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2012: 1 paper, 1 trial · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper
Papers 4
- A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma-TCOG T1211 study. First author DOI 10.1016/j.ejca.2019.10.023↗
- The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis. Last author DOI 10.1002/path.5341↗
- Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks. Co-author DOI 10.3390/jcm8050702↗
- Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ajpath.2012.04.025↗
Trials 1
- The Study of Metastatic Pancreatic Adenocarcinoma Principal investigator NCT01415713↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yan‐Shen Shan · 3 shared papers, 2012–2020 · strength 0.23
- Paper A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adeno… DOI 10.1016/j.ejca.2019.10.023↗
- Paper The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreati… DOI 10.1002/path.5341↗
- Paper Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma. DOI 10.1016/j.ajpath.2012.04.025↗
- Yuval Shaked · 1 shared paper, 2019 · strength 0.16
- Yulin Lin · 1 shared paper, 2020 · strength 0.11
- Nai‐Jung Chiang · 1 shared paper, 2020 · strength 0.11
- Jen‐Shi Chen · 1 shared paper, 2020 · strength 0.11
- Chiun Hsu · 1 shared paper, 2020 · strength 0.11
- Shih‐Hung Yang · 1 shared paper, 2020 · strength 0.11
- Li‐Tzong Chen · 1 shared paper, 2020 · strength 0.11
- Li-Tzong Chen · 1 shared trial, 2012 · strength 0.10
- Chung‐Chi Hsu · 1 shared paper, 2019 · strength 0.09
- Ya‐Chin Hou · 1 shared paper, 2019 · strength 0.09
- Hui-Ju Ch'ang · 1 shared paper, 2012 · strength 0.03
- Vincent H.S. Chang · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.